Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
81.07
+3.33 (4.28%)
Dec 22, 2025, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $4.17 billion as of December 23, 2025. Its market cap has increased by 95.48% in one year.
Market Cap
4.17B
Enterprise Value
4.11B
1-Year Change
95.48%
Ranking
Category
Stock Price
$81.07
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $4.17B, an increase of 1,301.78%. That is a compound annual growth rate of 50.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 4.17B | 109.90% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | 510.71M | -7.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |